Hemoperfusion for N-Acetylprocainamide Intoxication

  1. STEVEN C. BORKAN, M.D.
  1. Boston University Medical Center;
    Boston, MA 02118

    Excerpt

    To the editor: The data presented by Braden, and coworkers (1) do not show the clear superiority of hemoperfusion over hemodialysis for treatment of severe N-acetylprocainamide intoxication. The evidence is circumstantial that a markedly elevated level of this metabolite was responsible for precipitating the torsade de pointes because two separate episodes of ventricular arrhythmia occurred before any procainamide was administered, because the torsade de pointes occurred 3 days after intravenous procainamide therapy was discontinued, and because the N-acetylprocainamide level had already fallen from 56 to 49.5 /µg/mL. Although hemoperfusion produced an impressive 38% decrement in the plasma 7V-acetylprocainamide level (to

    This 100-word excerpt has been provided in the absence of an abstract.

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement